Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future ManagementAnca Pantea Stoian, Manfredi Rizzo, Yajnavalka Banerjee et al.|Metabolic Syndrome and Related Disorders|2020Cited by 105
Post-COVID syndrome, inflammation, and diabetesAli A. Rizvi, Manfredi Rizzo, Νικόλαος Παπάνας et al.|Journal of Diabetes and its Complications|2022Cited by 69
The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert PanelMojca Jensterle, Manfredi Rizzo, Rok Herman et al.|International Journal of Molecular Sciences|2022Cited by 69
Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options (Review)А. Е. Бондарь, Anca Pantea Stoian, Amorin Remus Popa et al.|Experimental and Therapeutic Medicine|2021Cited by 64
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention StudyAngelo Maria Patti, Manfredi Rizzo, Giuseppe Carruba et al.|Metabolites|2020Cited by 57